CSL (CSLLY) Stock Forecast & Price Target

$86.54 +0.07 (+0.08%)

(As of 12/20/2024 05:55 PM ET)

CSL - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Buy

Based on 1 Analyst Ratings

Sell
0

Hold
0

Buy
1

Based on 1 Wall Street analysts who have issued ratings for CSL in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 1 analysts, 1 has given a strong buy rating for CSLLY.

Consensus Price Target

N/A

Get the Latest News and Ratings for CSLLY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CSL and its competitors.

CSLLY Analyst Ratings Over Time

Type	Current Forecast 12/23/23 to 12/22/24	1 Month Ago 11/23/23 to 11/22/24	3 Months Ago 9/24/23 to 9/23/24	1 Year Ago 12/23/22 to 12/23/23
Strong Buy	1 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	N/A
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Strong Buy	Strong Buy	Strong Buy	N/A

This is the worst sign for the U.S. stock market in 50 years (Ad)

The Dow recently posted its worst losing streak since 1974. And one of America's most accurate analysts now says this is just the beginning of a new crisis that could be worse than the COVID crash, the dot-com crash, and even the Great Depression. Introducing "The Dead Zone"

Click here to see Dan's new, urgent warning about the U.S. market for 2025.

CSLLY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CSLLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CSL Stock vs. The Competition

Type	CSL	Medical Companies	S&P 500
Consensus Rating Score	4.00	2.81	2.51
Consensus Rating	Strong Buy	Moderate Buy	Moderate Buy
Predicted Upside	N/A	25,827.32% Upside	14.53% Upside
News Sentiment Rating	Positive News See Recent CSLLY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
8/13/2024	Macquarie 1 of 5 stars	D. Bailey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 12:48 AM ET.

Should I Buy CSL Stock? CSLLY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, December 17, 2024. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com.

CSL
Bull Case

Here are some ways that investors could benefit from investing in CSL Limited:

CSL Limited has a strong presence in the biopharmaceutical market, with a diverse portfolio that includes plasma products, gene therapies, and vaccines, which are in high demand globally.
The company operates through well-established segments, including CSL Behring, CSL Seqirus, and CSL Vifor, allowing for a balanced revenue stream across various therapeutic areas.
As of the latest record date, the stock price is $104.43, which may present a favorable entry point for investors looking to capitalize on potential growth in the biopharmaceutical sector.
CSL Limited's commitment to research and development positions it well for future innovations, particularly in gene therapies and treatments for iron deficiency, which are critical areas in healthcare.
The company has shown resilience in its performance, with a 52-week performance increase of 0.25%, indicating stability and potential for continued growth.

CSL
Bear Case

Investors should be bearish about investing in CSL Limited for these reasons:

There is a relatively low level of institutional ownership, currently at 0%, which may indicate a lack of confidence from larger investors in the company's future prospects.
The short interest has decreased significantly, with only 1,200 shares shorted, suggesting that some investors may be betting against the stock, which could indicate underlying concerns.
CSL Limited has a high average daily volume of 41,200 shares, which can lead to increased volatility, making it a riskier investment for those averse to price fluctuations.
The company has reported a month-to-month change percentage of -0.9464 in shares shorted, which may reflect a cautious sentiment among investors regarding its near-term performance.
With no outstanding shares reported, it raises questions about liquidity and the ability to attract new investors, which could hinder growth potential.

CSLLY Forecast - Frequently Asked Questions

: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There is currently 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "strong buy" CSLLY shares.
: According to analysts, CSL's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Analysts like CSL more than other "medical" companies. The consensus rating for CSL is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CSLLY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This is the worst sign for the U.S. stock market in 50 years (Ad)

Click here to see Dan's new, urgent warning about the U.S. market for 2025.

This page (OTCMKTS:CSLLY) was last updated on 12/22/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CSL (CSLLY) Stock Forecast & Price Target